SOCS3 and cancer: Cachexia-relevant myocellular responses to STAT3 activation include the upregulation of SOCS3 that promotes insulin resistance, proteolysis and mitochondria dysfunction, all of which are implicated in cancer cachexia [27,28] and its gender-related variability [29].